A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Clinical trial NCT00251797 · COMPLETED

Trial details

NCT number: NCT00251797
Sponsor: University of New Mexico
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Nervous System Cancer

Start date: 2000-03-01
Primary completion: 2006-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.